Show simple item record

dc.contributor.authorWinter, Rebecca
dc.contributor.authorYoung, J. T.
dc.contributor.authorStoové, Mark
dc.contributor.authorAgius, P. A.
dc.contributor.authorHellard, Margaret
dc.contributor.authorKinner, Stuart
dc.date.accessioned2018-04-30T04:58:42Z
dc.date.available2018-04-30T04:58:42Z
dc.date.issued2016
dc.identifier.issn0376-8716en_US
dc.identifier.doi10.1016/j.drugalcdep.2016.08.640en_US
dc.identifier.urihttp://hdl.handle.net/10072/124053
dc.description.abstractIntroduction: Ex-prisoners with a history of injecting drug use (IDU) experience disproportionate drugrelated harm. Rapid resumption of substance use following prison release is common and evidenced in high rates of overdose mortality. However, few studies have documented the rate of IDU resumption following prison release or identified risk factors for relapse. Methods: Structured interviews were conducted with 533 adults with a history of IDU in Queensland, Australia prior to release from prison and approximately 1, 3 and 6 months post-release. Incidence of selfreported IDU resumption was calculated overall and for each follow-up interval. Risk factors associated with time to resumption of IDU were estimated using discrete-time survival analysis. Results: IDU resumption was reported by 41% of participants during a median of 98 days of followup (IQR = 94–121), an overall crude incidence of 1.06 per person-year. The highest rate was observed in the first month (23%; crude incidence 2.24 per person-year). In adjusted discrete-time survival analyses, being unemployed at the previous interview (AHR = 1.59; 95%CI:1.10–2.30), shorter incarceration (≤90 days vs. >365 days; AHR = 2.20; 95%CI:1.33–3.65), and IDU during the index incarceration (AHR = 2.80; 95%CI:1.92–4.09) were significantly associated with time to IDU resumption; parole was protective (AHR = 0.66; 95%CI:0.47–0.92). Conclusions: Evidence-based efforts to prevent IDU in prison and IDU resumption after release are important for both prisoner and public health. Enhancing opportunities for employment and capitalising on the short-term benefits of parole for ex-prisoners may delay resumption of IDU after release from prison. These strategies should complement rather than replace harm reduction efforts for this high-risk population.en_US
dc.description.peerreviewedYesen_US
dc.languageEnglishen_US
dc.publisherElsevieren_US
dc.relation.ispartofpagefrom104en_US
dc.relation.ispartofpageto111en_US
dc.relation.ispartofjournalDrug and Alcohol Dependenceen_US
dc.relation.ispartofvolume168en_US
dc.subject.fieldofresearchMedical and Health Sciences not elsewhere classifieden_US
dc.subject.fieldofresearchcode119999en_US
dc.titleResumption of injecting drug use following release from prison in Australiaen_US
dc.typeJournal articleen_US
dc.type.descriptionC1 - Peer Reviewed (HERDC)en_US
dc.type.codeC - Journal Articlesen_US
dcterms.licensehttp://creativecommons.org/licenses/by-nc-nd/4.0/en_US
dc.description.versionPost-printen_US
gro.rights.copyright© 2016 Elsevier. Licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Licence (http://creativecommons.org/licenses/by-nc-nd/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, providing that the work is properly cited.en_US
gro.hasfulltextFull Text


Files in this item

This item appears in the following Collection(s)

  • Journal articles
    Contains articles published by Griffith authors in scholarly journals.

Show simple item record